Annual CFF
$68.03 M
+$52.01 M+324.78%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual cash flow from financing activities is $68.03 million, with the most recent change of +$52.01 million (+324.78%) on June 30, 2024.
- During the last 3 years, BNTC annual CFF has risen by +$45.51 million (+202.06%).
- BNTC annual CFF is now at all-time high.
Performance
BNTC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$21.66 M
-$18.42 M-45.96%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly cash flow from financing activities is $21.66 million, with the most recent change of -$18.42 million (-45.96%) on September 30, 2024.
- Over the past year, BNTC quarterly CFF has increased by +$21.62 million (+55425.64%).
- BNTC quarterly CFF is now -45.96% below its all-time high of $40.07 million, reached on June 30, 2024.
Performance
BNTC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$61.77 M
-$6.26 M-9.21%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM cash flow from financing activities is $61.77 million, with the most recent change of -$6.26 million (-9.21%) on September 30, 2024.
- Over the past year, BNTC TTM CFF has increased by +$33.81 million (+120.92%).
- BNTC TTM CFF is now -9.21% below its all-time high of $68.03 million, reached on June 30, 2024.
Performance
BNTC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BNTC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +324.8% | +10000.0% | +120.9% |
| 3 y3 years | +202.1% | +10000.0% | +120.9% |
| 5 y5 years | +100.0% | +10000.0% | +120.9% |
BNTC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -46.0% | -100.0% | -9.2% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -46.0% | -100.0% | -9.2% | -100.0% |
| alltime | all time | at high | -100.0% | -46.0% | +6601.1% | -9.2% | -100.0% |
Benitec Biopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.66 M(-46.0%) | $61.77 M(-9.2%) |
| Jun 2024 | $68.03 M(+324.8%) | $40.07 M(>+9900.0%) | $68.03 M(+143.3%) |
| Mar 2024 | - | $0.00(-100.0%) | $27.96 M(0.0%) |
| Dec 2023 | - | $39.00 K(-99.9%) | $27.96 M(+0.1%) |
| Sep 2023 | - | $27.92 M(>+9900.0%) | $27.92 M(+74.3%) |
| Jun 2023 | $16.02 M(>+9900.0%) | $0.00(0.0%) | $16.02 M(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $16.02 M(0.0%) |
| Dec 2022 | - | $0.00(-100.0%) | $16.02 M(0.0%) |
| Sep 2022 | - | $16.02 M(>+9900.0%) | $16.02 M(>+9900.0%) |
| Jun 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2022 | - | $0.00(0.0%) | $12.67 M(-0.0%) |
| Dec 2021 | - | $0.00(0.0%) | $12.67 M(-43.7%) |
| Sep 2021 | - | $0.00(-100.0%) | $22.52 M(0.0%) |
| Jun 2021 | $22.52 M(+1172.4%) | $12.67 M(>+9900.0%) | $22.52 M(+128.6%) |
| Mar 2021 | - | $3000.00(-100.0%) | $9.85 M(+0.0%) |
| Dec 2020 | - | $9.85 M(>+9900.0%) | $9.85 M(+456.6%) |
| Jun 2020 | $1.77 M | $0.00(0.0%) | $1.77 M(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $1.77 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $0.00(-100.0%) | $1.77 M(-0.8%) |
| Sep 2019 | - | $1.77 M(>+9900.0%) | $1.78 M(>+9900.0%) |
| Jun 2019 | $0.00(-100.0%) | $0.00(-100.0%) | $14.40 K(-99.8%) |
| Dec 2018 | - | $14.40 K(-99.8%) | $6.26 M(+0.2%) |
| Jun 2018 | $6.25 M(+2.4%) | $6.25 M(>+9900.0%) | $6.25 M(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) | $25.80 K(-99.4%) |
| Dec 2017 | - | $0.00(0.0%) | $4.30 M(-29.6%) |
| Sep 2017 | - | $0.00(-100.0%) | $6.10 M(0.0%) |
| Jun 2017 | $6.10 M(-53.3%) | $25.80 K(-99.4%) | $6.10 M(+6.3%) |
| Mar 2017 | - | $4.27 M(+136.7%) | $5.74 M(+169.4%) |
| Dec 2016 | - | $1.80 M(>+9900.0%) | $2.13 M(+150.6%) |
| Sep 2016 | - | $0.00(-100.0%) | $850.60 K(-93.5%) |
| Jun 2016 | $13.08 M(>+9900.0%) | -$333.10 K(-150.5%) | $13.08 M(-2.5%) |
| Mar 2016 | - | $660.20 K(+26.1%) | $13.41 M(+5.2%) |
| Dec 2015 | - | $523.50 K(-95.7%) | $12.75 M(+4.3%) |
| Sep 2015 | - | $12.23 M | $12.23 M |
| Jun 2015 | $39.90 K(-18.6%) | - | - |
| Jun 2014 | $49.00 K(-99.9%) | - | - |
| Jun 2013 | $35.66 M | - | - |
FAQ
- What is Benitec Biopharma annual cash flow from financing activities?
- What is the all time high annual CFF for Benitec Biopharma?
- What is Benitec Biopharma annual CFF year-on-year change?
- What is Benitec Biopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Benitec Biopharma?
- What is Benitec Biopharma quarterly CFF year-on-year change?
- What is Benitec Biopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Benitec Biopharma?
- What is Benitec Biopharma TTM CFF year-on-year change?
What is Benitec Biopharma annual cash flow from financing activities?
The current annual CFF of BNTC is $68.03 M
What is the all time high annual CFF for Benitec Biopharma?
Benitec Biopharma all-time high annual cash flow from financing activities is $68.03 M
What is Benitec Biopharma annual CFF year-on-year change?
Over the past year, BNTC annual cash flow from financing activities has changed by +$52.01 M (+324.78%)
What is Benitec Biopharma quarterly cash flow from financing activities?
The current quarterly CFF of BNTC is $21.66 M
What is the all time high quarterly CFF for Benitec Biopharma?
Benitec Biopharma all-time high quarterly cash flow from financing activities is $40.07 M
What is Benitec Biopharma quarterly CFF year-on-year change?
Over the past year, BNTC quarterly cash flow from financing activities has changed by +$21.62 M (+55425.64%)
What is Benitec Biopharma TTM cash flow from financing activities?
The current TTM CFF of BNTC is $61.77 M
What is the all time high TTM CFF for Benitec Biopharma?
Benitec Biopharma all-time high TTM cash flow from financing activities is $68.03 M
What is Benitec Biopharma TTM CFF year-on-year change?
Over the past year, BNTC TTM cash flow from financing activities has changed by +$33.81 M (+120.92%)